U of Minnesota sixth in money gained from tech licensing
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
The University of Minnesota is sixth -- out of 153 universities -- in the amount money made through the commercialization of university research, according to a study written up in MedCity News.
Ziagen (Abacavir) -- used in the treatment of HIV -- is a huge source of licensing income for the U. According to the Minnesota Daily in 2010:
... Royalties on the patent for Ziagen, an AIDS-combating drug manufactured by GlaxoSmithKline, accounted for over 90 percent of the (U of M Office for Technology Commercialization) revenues in fiscal year 2009.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
In any case, the income has jumped recently, the Minnesota Daily wrote:
The University of Minnesota Office for Technology Commercialization’s revenues have nearly doubled in the past six years, from $48.4 million in 2004 to $95.2 million in 2009.
That said, regents have already discussed how that income could take a hit when the license runs out.
Below is the ranking. You can read the full story here.
1. Northwestern University, $161 million
2. Columbia University, $154 million
3. New York University, $113 million
4. University of California System, $103 million
5. Wake Forest University, $96 million
6. University of Minnesota, $95 million
7. University of Washington/Washington Research Foundation, $87 million
8. University of Massachusetts, $71 million
9. Massachusetts Institute of Technology, $66 million
10. Stanford University, $64 million
11. University of Wisconsin at Madison, $57 million
12. University of Florida, $54 million
13. California Institute of Technology, $48 million
14. University of Rochester, $46 million
15. University of Iowa Research Foundation, $43 million
